Page last updated: 2024-10-20

pyrazinamide and Conjunctival Diseases

pyrazinamide has been researched along with Conjunctival Diseases in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Conjunctival Diseases: Diseases involving the CONJUNCTIVA.

Research Excerpts

ExcerptRelevanceReference
"All cases had evidence of pulmonary tuberculosis."1.33Ocular tuberculosis in acquired immunodeficiency syndrome. ( Babu, RB; Biswas, J; Kumarasamy, N; Sudharshan, S; Therese, L, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsia, YC1
Naseri, A1
Schallhorn, JM1
Babu, RB1
Sudharshan, S1
Kumarasamy, N1
Therese, L1
Biswas, J1

Other Studies

2 other studies available for pyrazinamide and Conjunctival Diseases

ArticleYear
A Painful Red Eye.
    JAMA ophthalmology, 2018, Mar-01, Volume: 136, Issue:3

    Topics: Alcoholism; Antitubercular Agents; Conjunctival Diseases; Ethambutol; Eye Pain; Glucocorticoids; Hum

2018
Ocular tuberculosis in acquired immunodeficiency syndrome.
    American journal of ophthalmology, 2006, Volume: 142, Issue:3

    Topics: Abscess; Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lympho

2006